Skip to main content
. Author manuscript; available in PMC: 2020 May 2.
Published in final edited form as: Pancreatology. 2019 Nov 21;20(1):101–109. doi: 10.1016/j.pan.2019.11.011

Table 1A—

Cohort I dose escalation (all cycles)

Dose levels Erlotinib (mg/day)* Vismodegib (mg/day)
−1 25 150
1 50 150
2 75 150
3 100 150
4** 150 150
*

As assigned by the Registration Office upon enrollment

**

Dose level used in cohort III

Cycle length = 28 days; for all cycles, Erlotinib and Vismodegib taken orally on days 1-28.

Erlotinib and Vismodegib taken on an empty stomach (1 hour prior to or 2 hours after eating)